Collectively, these dates indicated that treatment of plive-IL-28B could alleviate papain-induced AHR and infiltration of inflammatory cells including eosinophils and neutrophils, suggesting a protective role of IL-28B in papain-induced asthma model. The gene discussed is IFNL3; the disease is asthma.